These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34292887)

  • 1. Return to Work and Associated Costs after Treatment for Dupuytren's Disease.
    Blake SN; Poelstra R; Andrinopoulou ER; Obdeijn MC; van de Oest MJW; Feitz R; Burdorf A; Selles RW
    Plast Reconstr Surg; 2021 Sep; 148(3):580-590. PubMed ID: 34292887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.
    Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T
    Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Percutaneous Needle Aponeurotomy and Limited Fasciectomy for Dupuytren's Contracture: A Multicenter Observational Study.
    Zhou C; Selles RW; Slijper HP; Feitz R; van Kooij Y; Moojen TM; Hovius SER
    Plast Reconstr Surg; 2016 Oct; 138(4):837-846. PubMed ID: 27307334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Aponeurotomy and Lipofilling (PALF) versus Limited Fasciectomy in Patients with Primary Dupuytren's Contracture: A Prospective, Randomized, Controlled Trial.
    Kan HJ; Selles RW; van Nieuwenhoven CA; Zhou C; Khouri RK; Hovius SER
    Plast Reconstr Surg; 2016 Jun; 137(6):1800-1812. PubMed ID: 27219235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.
    Toppi JT; Trompf L; Smoll NR; Lim V; Smith K; Findlay MW; Hunter-Smith DJ
    ANZ J Surg; 2015 Sep; 85(9):639-43. PubMed ID: 24438029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.
    van Rijssen AL; Ter Linden H; Werker PMN
    Plast Reconstr Surg; 2012 Feb; 129(2):469-477. PubMed ID: 21987045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England.
    Gerber RA; Perry R; Thompson R; Bainbridge C
    BMC Musculoskelet Disord; 2011 Apr; 12():73. PubMed ID: 21486483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (Hand-2): study protocol for a randomised controlled trial.
    Harrison S; Ogollah R; Hollingworth W; Mills N; Karantana A; Blazeby J; Montgomery A; Shafayat A; Jarrett H; Davis T
    Trials; 2024 Jun; 25(1):398. PubMed ID: 38898458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy for Dupuytren's Contracture: 5-Year Results from a Randomized Clinical Trial.
    Selles RW; Zhou C; Kan HJ; Wouters RM; van Nieuwenhoven CA; Hovius SER
    Plast Reconstr Surg; 2018 Dec; 142(6):1523-1531. PubMed ID: 30489526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on costs of switching one-ray aponeurectomy to percutaneous needle aponeurotomy in Dupuytren's disease: A model analysis.
    Maravic M; Beaudreuil J
    Joint Bone Spine; 2015 Jul; 82(4):264-6. PubMed ID: 25857217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren's disease undergoing collagenase versus fasciectomy treatment.
    Vukicevic D; Tatovic S; Zah V; Hurley D; Imro M
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):127-136. PubMed ID: 32408788
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of Recurrent Surgery in Dupuytren's Disease: Comparison with Initial Treatment.
    Mendelaar NHA; Poelstra R; van Nieuwenhoven CA; Slijper HP; Feitz R; Hovius SER; Selles RW
    Plast Reconstr Surg; 2019 Nov; 144(5):828e-835e. PubMed ID: 31397794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised feasibility trial comparing needle fasciotomy with limited fasciectomy treatment for Dupuytren's contractures.
    Davis TRC; Tan W; Harrison EF; Hollingworth W; Karantana A; Mills N; Hepburn T; Sprange K; Duley L; Blazeby JM; Bainbridge CG; Murali SR; Montgomery AA;
    Pilot Feasibility Stud; 2020; 6():7. PubMed ID: 32021696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Dupuytren's disease; limited fasciectomy versus percutaneous needle fasciotomy].
    Broekstra DC; van den Berge BA
    Ned Tijdschr Geneeskd; 2024 Jul; 168():. PubMed ID: 39132896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
    Abe Y
    Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren's disease.
    Moog P; Buchner L; Cerny MK; Schmauss D; Megerle K; Erne H
    Arch Orthop Trauma Surg; 2019 Oct; 139(10):1471-1477. PubMed ID: 31367843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited fasciectomy with versus without autologous adipose tissue grafting for treatment of Dupuytren's contracture (REMEDY): study protocol for a multicentre randomised controlled trial.
    Sawaya ET; Sommier B; Alet JM; Piechaud PT; ; ; Lecoq FA
    Trials; 2024 Sep; 25(1):577. PubMed ID: 39223657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.